JPH3 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "JPH3" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

11^th place

8^th place

1,626^th place

1,007^th place

doi.org

Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K (July 2000). "Junctophilins: a novel family of junctional membrane complex proteins". Molecular Cell. 6 (1): 11–22. doi:10.1016/S1097-2765(05)00005-5. PMID 10949023.
Nishi M, Mizushima A, Nakagawara K, Takeshima H (July 2000). "Characterization of human junctophilin subtype genes". Biochemical and Biophysical Research Communications. 273 (3): 920–927. doi:10.1006/bbrc.2000.3011. PMID 10891348.
Nishi M, Hashimoto K, Kuriyama K, Komazaki S, Kano M, Shibata S, Takeshima H (March 2002). "Motor discoordination in mutant mice lacking junctophilin type 3". Biochemical and Biophysical Research Communications. 292 (2): 318–324. doi:10.1006/bbrc.2002.6649. PMID 11906164.
Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, et al. (February 2012). "Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis". Annals of Neurology. 71 (2): 245–257. doi:10.1002/ana.22598. PMID 22367996. S2CID 6432652.
Chen Z, Sequeiros J, Tang B, Jiang H (December 2018). "Genetic modifiers of age-at-onset in polyglutamine diseases". Ageing Research Reviews. 48: 99–108. doi:10.1016/j.arr.2018.10.004. PMID 30355507. S2CID 53027229.
Fan HC, Ho LI, Chi CS, Chen SJ, Peng GS, Chan TM, et al. (May 2014). "Polyglutamine (PolyQ) diseases: genetics to treatments". Cell Transplantation. 23 (4–5): 441–458. doi:10.3727/096368914X678454. PMID 24816443. S2CID 27522175.

Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K (July 2000). "Junctophilins: a novel family of junctional membrane complex proteins". Molecular Cell. 6 (1): 11–22. doi:10.1016/S1097-2765(05)00005-5. PMID 10949023.
Nishi M, Mizushima A, Nakagawara K, Takeshima H (July 2000). "Characterization of human junctophilin subtype genes". Biochemical and Biophysical Research Communications. 273 (3): 920–927. doi:10.1006/bbrc.2000.3011. PMID 10891348.
Nishi M, Hashimoto K, Kuriyama K, Komazaki S, Kano M, Shibata S, Takeshima H (March 2002). "Motor discoordination in mutant mice lacking junctophilin type 3". Biochemical and Biophysical Research Communications. 292 (2): 318–324. doi:10.1006/bbrc.2002.6649. PMID 11906164.
Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, et al. (February 2012). "Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis". Annals of Neurology. 71 (2): 245–257. doi:10.1002/ana.22598. PMID 22367996. S2CID 6432652.
Chen Z, Sequeiros J, Tang B, Jiang H (December 2018). "Genetic modifiers of age-at-onset in polyglutamine diseases". Ageing Research Reviews. 48: 99–108. doi:10.1016/j.arr.2018.10.004. PMID 30355507. S2CID 53027229.
Fan HC, Ho LI, Chi CS, Chen SJ, Peng GS, Chan TM, et al. (May 2014). "Polyglutamine (PolyQ) diseases: genetics to treatments". Cell Transplantation. 23 (4–5): 441–458. doi:10.3727/096368914X678454. PMID 24816443. S2CID 27522175.

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, et al. (February 2012). "Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis". Annals of Neurology. 71 (2): 245–257. doi:10.1002/ana.22598. PMID 22367996. S2CID 6432652.
Chen Z, Sequeiros J, Tang B, Jiang H (December 2018). "Genetic modifiers of age-at-onset in polyglutamine diseases". Ageing Research Reviews. 48: 99–108. doi:10.1016/j.arr.2018.10.004. PMID 30355507. S2CID 53027229.
Fan HC, Ho LI, Chi CS, Chen SJ, Peng GS, Chan TM, et al. (May 2014). "Polyglutamine (PolyQ) diseases: genetics to treatments". Cell Transplantation. 23 (4–5): 441–458. doi:10.3727/096368914X678454. PMID 24816443. S2CID 27522175.